Cargando…
Characterization of human mesothelin transcripts in ovarian and pancreatic cancer
BACKGROUND: Mesothelin is an attractive target for cancer immunotherapy due to its restricted expression in normal tissues and high level expression in several tumor types including ovarian and pancreatic adenocarcinomas. Three mesothelin transcript variants have been reported, but their relative ex...
Autores principales: | Muminova, Zhanat E, Strong, Theresa V, Shaw, Denise R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420467/ https://www.ncbi.nlm.nih.gov/pubmed/15140265 http://dx.doi.org/10.1186/1471-2407-4-19 |
Ejemplares similares
-
Targeting mesothelin in ovarian cancer
por: Ghafoor, Azam, et al.
Publicado: (2018) -
The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
por: Yu, Yi, et al.
Publicado: (2011) -
The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment
por: Hilliard, Tyvette S.
Publicado: (2018) -
Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment
por: Zhang, Xianyu, et al.
Publicado: (2022) -
Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients’ Sera
por: Duran, Adrià, et al.
Publicado: (2022)